| | 866460-33-5 Basic information More.. |
| Product Name: | Setipiprant | | Synonyms: | 2-(2-(1-naphthoyl)-8-fluoro-1,2,3,4-tetrahydropyrido[4,3-b]indol-5-yl)acetic acid;Setipiprant;ACT129968;2-[8-fluoro-2-(naphthalene-1-carbonyl)-3,4-dihydro-1H-pyrido[4,3-b]indol-5-yl]acetic acid;ACT-129968 (Setipiprant);8-Fluoro-1,2,3,4-tetrahydro-2-(1-naphthalenylcarbonyl)-5H-pyrido[4,3-b]indole-5-acetic acid;2-(2-(1-Naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic acid;ACT 129968; ACT129968; KYTH-105; KYTH105; KYTH 105; SETIPIPRANT | | CAS: | 866460-33-5 | | MF: | C24H19FN2O3 | | MW: | 402.42 | | EINECS: | | | Mol File: | 866460-33-5.mol |  |
Use
Setipiprant, also known as ACT-129968 and KYTH-105, is a potent and selective CRTH2 antagonist. Setipiprant at multiple oral doses was well tolerated and reduced both the allergen-induced LAR and the associated AHR in allergic asthmatics. Setipiprant may be a promising target for the treatment of allergic disorders.
- Setipiprant
-
- US $0.00 / KG
- 2025-05-16
- CAS:866460-33-5
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 50000KG/month
- Setipiprant
-
- US $0.00-0.00 / kg
- 2025-04-29
- CAS:866460-33-5
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 500
- Setipiprant
-
- US $39.00-118.00 / mg
- 2025-04-27
- CAS:866460-33-5
- Min. Order:
- Purity: 99.16%
- Supply Ability: 10g
|
|
866460-33-5
Recommend Suppliers |
|